清纯女被强行糟蹋视频,日本熟女诱惑中文字幕,青青在线经典视频在线,亚洲国产一区二区三区在线观看,午夜福利视频10000在线观看,最近中文字幕完整国语版,老色鬼久久亚洲AV综合0男男

In 2020, as Kexing Biopharm overcame the impact of COVID-19 and insisted on stable operation, it achieved a revenue of RMB 1.22 billion, net profit of RMB 139 million and net cash flow of RMB 106 million. Then, it kept enhancing the exploration of sales terminals and promoting fine market channels management. By 2020, Kexing Biopharm's products have been adopted by more than 16,000 sales terminals in China, including more than 6,000 hospitals, and have been registered in, exported and sold to more than 30 countries. Kexing Biopharm has achieved a sustained increase in R&D investment, up 30.20% year-on-year, accelerated the layout of innovative drug projects, and made steady progress in ongoing projects. Finally, it was listed on the Sci-Tech Innovation Board in the A-share market (stock code: 688136), which was deemed as a new historic leap.